ISOVUE-250 Drug Patent Profile
✉ Email this page to a colleague
When do Isovue-250 patents expire, and what generic alternatives are available?
Isovue-250 is a drug marketed by Bracco and is included in two NDAs.
The generic ingredient in ISOVUE-250 is iopamidol. There are eleven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the iopamidol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Isovue-250
A generic version of ISOVUE-250 was approved as iopamidol by HAINAN POLY on February 27th, 2023.
Summary for ISOVUE-250
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 79 |
Clinical Trials: | 20 |
Patent Applications: | 3,520 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ISOVUE-250 |
DailyMed Link: | ISOVUE-250 at DailyMed |
Recent Clinical Trials for ISOVUE-250
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
NYU Langone Health | N/A |
M.D. Anderson Cancer Center | N/A |
National Cancer Institute (NCI) | N/A |
Pharmacology for ISOVUE-250
Drug Class | Radiographic Contrast Agent |
Mechanism of Action | X-Ray Contrast Activity |
Anatomical Therapeutic Chemical (ATC) Classes for ISOVUE-250
US Patents and Regulatory Information for ISOVUE-250
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bracco | ISOVUE-250 | iopamidol | INJECTABLE;INJECTION | 018735-007 | Jul 6, 1992 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Bracco | ISOVUE-250 | iopamidol | INJECTABLE;INJECTION | 020327-002 | Oct 12, 1994 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ISOVUE-250
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bracco | ISOVUE-250 | iopamidol | INJECTABLE;INJECTION | 018735-007 | Jul 6, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
Bracco | ISOVUE-250 | iopamidol | INJECTABLE;INJECTION | 020327-002 | Oct 12, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ISOVUE-250
See the table below for patents covering ISOVUE-250 around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | S5182236 | MIZUNIIYOSEINO 2 4 66 TORYOODOOISOFUTARUSANAMIDORUINO SEIHO | ⤷ Try a Trial |
Yugoslavia | 196683 | ⤷ Try a Trial | |
Mexico | 5979 | ⤷ Try a Trial | |
Hungary | 170216 | ⤷ Try a Trial | |
Norway | 145096 | ⤷ Try a Trial | |
South Africa | 7507222 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |